Spurs signing Julian Champagnie to new 3-year, $45 million deal after NBA Finals run
Champagnie led San Antonio with 512 3-point attempts, hitting 38% of them, and played in all 82 games for the past two seasons.
Millions of women with menopause barred from hormone replacement therapy because of health risk
Hormone replacement therapy is having a resurgence as more doctors prescribe it to treat menopause symptoms. But millions of women with menopause can't take HRT due to medical reasons, including breast cancer survivors. Dr. Mindy Goldman, chief clinica...
6/29: The Takeout with Major Garrett
Takeaways from Monday's Supreme Court decisions; Trump says U.S. and Iran will hold talks Tuesday, Iranians say otherwise.
Collin Gosselin sends cryptic signal to mom Kate after claims she’s ‘spiraling’ over his upcoming memoir
Collin Gosselin shared a thinly-veiled message about Kate Gosselin on Instagram after announcing memoir about growing up on "Jon & Kate Plus 8."
U.S. eases restrictions on Anthropic’s Mythos AI model
The Trump administration is allowing Anthropic to restore access to its Mythos 5 AI model for a select group of U.S. companies and federal agencies. New York Times tech reporter Sheera Frenkel joins CBS News to discuss.
Utah mayor on wildfires: “Wrapping our heads around the damage”
Matt Robinson, the mayor of Beaver, Utah, joins CBS News to discuss the ongoing wildfires that have been burning across the state.
New York Times blames ‘misogyny,’ fans for ‘Supergirl’ flop after disastrous opening weekend
Warner Bros studio executives and the New York Times blame fans for "Supergirl" box office failure after star Milly Alcock made divisive comments.
Grizzlies trade Ja Morant to Trail Blazers, ending tumultuous tenure in Memphis: report
The Memphis Grizzlies have ended their ties with point guard Ja Morant, as they're reportedly trading him to the Portland Trail Blazers in exchange for two players.
Rare tick-borne virus turns deadly fast as US cases reach record high, experts warn
Powassan virus, a rare tick-borne illness traced to a 1958 case, has hit record highs in 2025, with 76 U.S. diagnoses and no vaccine available.
Atlanta Hawks reportedly decline Jonathan Kuminga's team option after trade with Warriors at deadline
Jonathan Kuminga was dealt to the Hawks after a tumultuous finish with the Warriors last season.
